Graham Litchman

Impact of a prognostic 40-gene expression profiling test on clinical management decisions for high-risk cutaneous squamous cell carcinoma

Graham Litchman, Alison L. Fitzgerald, Sarah J. Kurley et al. · Current Medical Research and Opinion · 2020 · 16 citations · Full text

The continuing impact of COVID-19 on dermatology practice: Office workflow, economics, and future implications

Graham Litchman, Justin W. Marson, Darrell S. Rigel · Journal of the American Academy of Dermatology · 2020 · 15 citations · Full text

Dermatology Practice, Contact Tracing, Preventive Medicine +10

Appropriate Use Criteria for the Integration of Diagnostic and Prognostic Gene Expression Profile Assays into the Management of Cutaneous Malignant Melanoma: An Expert Panel Consensus-Based Modified Delphi Process Assessment

Brian Berman, Roger I. Ceilley, Clay J. Cockerell et al. · SKIN The Journal of Cutaneous Medicine · 2019 · 14 citations · Full text

Cutaneous Malignant Melanoma, Oncology, Medicine +13

Real-World Evidence Shows Clinicians Appropriately Use the Prognostic 40-Gene Expression Profile (40-GEP) Test for High-Risk Cutaneous Squamous Cell Carcinoma (cSCC) Patients

Perry B. Hooper, Aaron S. Farberg, Alison L. Fitzgerald et al. · Cancer Investigation · 2022 · 12 citations

Oncology, Metastatic Risk Prediction, Medicine +11

Impact of Gene Expression Profile Testing on the Management of Squamous Cell Carcinoma by Dermatologists

Teplitz Rebeca, Prado Giselle, Graham Litchman et al. · PubMed · 2019 · 11 citations